These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22378254)

  • 1. Advancing the development of tuberculosis therapy.
    Zumla A; Hafner R; Lienhardt C; Hoelscher M; Nunn A
    Nat Rev Drug Discov; 2012 Mar; 11(3):171-2. PubMed ID: 22378254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unorthodox approach to the development of a new antituberculosis therapy.
    Barry CE
    N Engl J Med; 2009 Jun; 360(23):2466-7. PubMed ID: 19494223
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug development: A combined effort.
    Maxmen A
    Nature; 2013 Oct; 502(7470):S4-6. PubMed ID: 24108079
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 6. Public-private partnership tackles TB challenges in parallel.
    Webb S
    Nat Rev Drug Discov; 2009 Aug; 8(8):599-600. PubMed ID: 19644463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TB Alliance: overcoming challenges to chart the future course of TB drug development.
    Ginsberg A
    Future Med Chem; 2011 Aug; 3(10):1247-52. PubMed ID: 21859299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the development of new tuberculosis drugs and treatment regimens.
    Zumla A; Nahid P; Cole ST
    Nat Rev Drug Discov; 2013 May; 12(5):388-404. PubMed ID: 23629506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis clinical trial update and the current anti-tuberculosis drug portfolio.
    Palomino JC; Martin A
    Curr Med Chem; 2013; 20(30):3785-96. PubMed ID: 23862617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicine. New TB drug promises shorter, simpler treatment.
    Cohen J
    Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational use of moxifloxacin for tuberculosis treatment.
    Cox H; Ford N; Keshavjee S; McDermid C; von Schoen-Angerer T; Mitnick C; Goemaere E
    Lancet Infect Dis; 2011 Apr; 11(4):259-60. PubMed ID: 21453864
    [No Abstract]   [Full Text] [Related]  

  • 13. New anti-tuberculosis drugs with novel mechanisms of action.
    Rivers EC; Mancera RL
    Curr Med Chem; 2008; 15(19):1956-67. PubMed ID: 18691051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V
    Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
    Tasneen R; Li SY; Peloquin CA; Taylor D; Williams KN; Andries K; Mdluli KE; Nuermberger EL
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5485-92. PubMed ID: 21930883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tuberculosis drugs on the horizon.
    Cole ST; Riccardi G
    Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the health of the tuberculosis drug pipeline.
    Burki T
    Lancet Infect Dis; 2014 Feb; 14(2):102-3. PubMed ID: 24605379
    [No Abstract]   [Full Text] [Related]  

  • 19. Gradual filling up of TB drug pipeline: how can we play our role better?
    Kant L
    Indian J Tuberc; 2009 Jan; 56(1):1-4. PubMed ID: 19402265
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the tuberculosis drug development pipeline.
    Evangelopoulos D; McHugh TD
    Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.